For starters, she pointed out that standard CAR-T therapy involves a lymphodepletion regimen with cyclophosphamide and ...

Hydroxychloroquine (HCQ) doses of at least 400 mg/day provided better symptom relief for Taiwanese people with systemic lupus ...

In patients with relapsed or refractory systemic lupus erythematosus, allogeneic CAR-NK cell therapy may offer a safe ...

Fate Therapeutics, a biopharmaceutical company based in San Diego, is working on a groundbreaking investigational treatment for lupus.

Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers and severe pain for six years. She saved her life by begging for one more test in an emergency room about to ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...

Following this week's European Commission approval of Roche/Genentech's Gazyvaro (obinutuzumab) for the treatment of lupus nephritis (LN), Spherix Global Insights' latest RealTime Dynamix(TM): Lupus ...

Objectives The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for ...

AstraZeneca ( ($GB:AZN) ) has shared an announcement. AstraZeneca’s Saphnelo has been approved by the European Union for subcutaneous ...

A new study finds that experiences of discrimination are associated with worse patient-reported lupus-related symptoms and depressive symptoms among people with systemic lupus erythematosus (SLE).

InnoCare receives China NMPA approval to initiate phase II trial of TYK2 inhibitor ICP-488 for cutaneous lupus erythematosus: Beijing Wednesday, December 24, 2025, 18:00 Hrs [IST] ...